A Dose of Reality with Charles Spence

In this episode Charles discusses with Val, the previous VP of Medical Affairs at ITM and AAA, the importance of genuine relationship-building and personal presence in the field of Medical Affairs and pharmaceutical industry leadership.Val emphasizes that success in this field isn't just about scientific knowledge or achieving immediate results. Instead, it's about how you behave as a person, your ability to be present and attentive in interactions, and your capacity to build long-term relationships based on trust and transparency.He sums this up nicely with the quote: "Attention is the rarest and purest form of generosity."Here's what you're in for:03:00 Starting a Career in Nuclear Pharmacy07:07 Moving to Medical Affairs10:03 Making Connections in Medical Affairs18:38 Difficulties and Skills Needed in Medical Affairs23:25 Building a Good Medical Affairs Team28:22 Leadership Growth: Pros and Cons29:19 Handling Growth and People in Organizations31:15 Keeping Staff in Expanding Companies36:42 When and How to Hire the Right People45:15 Overused Words in Job Ads51:19 Wrapping Up and Last IdeasAbout Val NassiriDr. Val Nassiri, MBA, PharmD, Head of Medical Affairs U.S., leads the Medical Affairs team at ITM. He works on strategic plans for radiopharmaceutical projects. Before this, Val was the Head of Medical Affairs at AAA, a Novartis company. He also worked as Senior Director at Daiichi Sankyo. There, he formed teams and made partnerships to help with research. His aim was to help patients live longer. Val graduated from the Bernard J. Dunn School of Pharmacy in Virginia.Connect with Val:LinkedIn: https://www.linkedin.com/in/val-nassiri-pharmd-mba-84b7961/About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles explore the concept of 'empathy bridges' and how they can be used to improve communication and relationships within the workplace.It also covers empathy in overcoming work challenges, featuring case studies and personal stories, and offers steps to build empathy bridges, vital for career progression.Here's what to expect:01:36 How Empathy Helps in Talking to Others01:55 Knowing the Hard Parts of Work03:12 What an Empathy Bridge Is and Why It Matters07:44 A True Story: Leading with Empathy09:49 Steps to Make Empathy Bridges11:46 Wrapping Up and Last IdeasAbout CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles interviews Sabine Brookman-May, VP of Oncology R&D at Johnson and Johnson. They cover her path from being the first college graduate in her family to working at J&J, transitioning from hospitals to pharmaceuticals, and lessons from successful and failed drug trials.Sabine shares insights on balancing a demanding career with family, the importance of diversity in the workplace, effective team communication, and leadership. She concludes by discussing the role of mentors in her professional development.Here's what you're in for:00:57 Childhood and Education Journey03:27 Choosing a Career in Medicine09:55 Career Path and Industry Transition16:32 Challenges and Successes in Drug Development32:41 Leadership and Workplace Culture38:46 Quickfire Questions and ConclusionAbout Sabine Brookman-MayProf. Sabine Brookman-May is a urologist, cancer expert, and sports medicine doctor. She is the Vice President of Cancer Research & Development at Johnson & Johnson Innovative Medicine. There, she leads the work on new cancer treatments. Her leadership and new ideas are key in creating new therapies in the cancer field.Connect with Sabine:LinkedIn: https://www.linkedin.com/in/prof-dr-med-sabine-d-brookman-may-48115728/Website: https://www.janssen.com/Twitter: https://x.com/brookmans76About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles dives into the often misunderstood art of selling. He corrects the misconception that selling is just about having the right answers and emphasizes the importance of asking good questions to uncover real needs and concerns, leading to more impactful conversations.He outlines a four-step sales strategy and go through relatable stories and practical advice, this episode guides listeners to improve their selling and communication skills.Here's what you're in for:02:21 The Biggest Myth in Selling03:44 Why Questions Matter04:32 Examples of Simple Questions05:37 How Conditioning Affects Selling08:06 Tips for Good Selling12:42 Stories from Real Life and a Plan19:40 Wrapping Up and Final ThoughtsAbout CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles talks with Crystal Zuckerman, the VP HR of PMV Pharma. They discuss her transition from a large biotech firm like Celgene to a startup biotech. They also talk about how she handles layoffs carefully and the power of personal connections in advancing a career.Crystal shares how she brings a personal touch to HR by emphasizing authenticity, accountability and community-building at PMV.Here's what you are in for:00:50 HR's Role in Biotech Changes01:30 Crystal's HR Path and Move to PMV05:03 Big Changes in Biotech: Celgene Joins BMS08:30 Adjusting to a Smaller Company Feel During COVID17:28 Building Responsibility and Influence at Every Level21:15 Handling Job Cuts in Biotech21:36 Leading Company Changes with Kindness23:28 How to Share Tough News23:49 Improving Help for Those Leaving Jobs25:11 Looking Back on the Layoff Process and Responses27:08 Making Layoffs More Personal32:16 Tips for Interviews35:33 Debunking Interview Myths and Sharing Tips40:25 Helping Careers Grow with Project OnRampAbout Crystal ZuckermanCrystal Zuckerman serves as PMV Pharma's Vice President of Human Resources, bringing over 20 years of industry expertise. Her tenure includes a significant stint at Celgene before its acquisition by BMS, after which she joined the more nimble PMV Pharma about 3.5 years ago. A proponent of authenticity and community in corporate culture, Crystal recently managed a sensitive restructuring, ensuring generous support for those affected.About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles shares a story about a talented medical oncologist who struggled to progress in his career, both internally and externally at his company, despite being highly skilled technically.The main issue was the candidate's inability to effectively sell his achievements and communicate his worth. This inspires Charles to create a series focused on helping professionals, especially those in scientific/medical fields, overcome the challenges of self-promotion for career advancement.Here's what you are in for:00:06 Introduction00:29 Why you can't promotion03:45 Sell yourself the right way05:56 Final thoughtsAbout CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode,Charles talks with Amber Tong, a senior editor at Endpoints News, about how the Biosecure Act could impact the biotech and pharma sectors.Amber shares thoughts on how this law could change U.S.-China biopharma ties, jobs, and making medicines. We also look into how things are changing in this area, who might benefit or not, and the big global tensions that affect these shifts. Here's what you are in for:00:00 Introduction00:33 Welcoming the Guest02:36 Discussing the Biosecure Act04:34 Impact on the Biotech Industry07:17 Geopolitical Tensions and Historical Context16:09 Potential Winners and Losers35:16 Future Predictions and ConclusionAbout Amber TongAmber Tong is a senior editor at Endpoints News, which is a global specialty publication covering the biotech and pharmaceutical industries. She's a reporter/editor with more than six years of experience covering the biopharma industry, with a particular focus on the growing role China plays on the global stage.Amber is also at BIO San Diego 2024, go say hi. Useful Information on BIOSECUREEndpoints' latest articles:BIO: China tensions, fixing gene therapy’s business model, and the stop-start market recoveryhttps://endpts.com/see-you-at-bio-china-tensions-fixing-gene-therapys-business-model-and-the-stop-start-market-recovery/WuXi became a critical partner to biopharma companies. They’re not ready if the US cracks downhttps://endpts.com/wuxi-became-a-critical-partner-to-biopharma-companies-theyre-not-ready-if-the-us-cracks-down/The US could upend biopharma manufacturing. WuXi rivals have an openinghttps://endpts.com/the-us-could-upend-biopharma-manufacturing-wuxi-rivals-have-an-opening/US-China tensions threaten to ensnare additional Chinese biopharma contractorshttps://endpts.com/us-china-tensions-threaten-to-ensnare-additional-chinese-biopharma-contractors/New Biosecure draft features 2032 grandfather clause, five-year grace period for added companieshttps://endpts.com/new-biosecure-draft-features-2032-grandfather-clause-five-year-grace-period-for-added-companies/BIO CEO defends the organization's about-face on the Biosecure Acthttps://endpts.com/bio-ceo-defends-the-organizations-about-face-on-the-biosecure-act/Medicxi backs Chinese biotech's next-gen KRAS G12C drug with $40M injectionhttps://endpts.com/medicxi-backs-d3-bios-next-gen-kras-g12c-drug-with-40m-injection/About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH. Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website:  https://www.discera-search.com/

In this episode, Charles talks about his top rules for success in recruiting, which he calls 'The 10 Commandments of Recruitment.' He believes that having principles or commandments as a person or business is what sets us apart.He also shares a bit of fun insight about who he is and what he believes in business.Here's what you are in for:00:08 The 10 Commandments of Recruitment00:14 Commandment 1: Always Give Feedback00:47 Commandment 2: Don't Add to the Problem02:47 Commandment 3: It's Not Personal03:20 Commandment 4: Pride in Work Before Business04:18 Commandment 5: Always Be Learning05:07 Commandment 6: Understand Before Advising06:04 Commandment 7: Don't Be an Idiot06:15 Commandment 8: Be Refreshingly Honest07:01 Commandment 9: Be Authentic08:00 Commandment 10: Be Different and Keep GoingAbout CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Colin Hayward, CMO of Telix- a commercial-stage biopharmaceutical company, talks about his contribution to the success of Rituximab which culminated in transforming it into a $3 billion radiopharmaceutical giant.He also shares invaluable insights into the challenges of leadership, the burden of firing people, and the strategic decisions that drive success in the fast-paced world of biotech innovation.Here's what you are in for:01:36 Colin's Switch from Medicine to Biotech 04:15 Moving from Treating Patients to Business05:58 Lessons from Working on Rituxan10:59 Changing Careers: Consulting, CROs, and Teamwork23:03 Tips on Hiring and Making a Strong Biotech Team27:45 The burden of Firing peopleAbout Colin HaywardColin Hayward, MD is the former Chief Medical Officer at Telix Pharmaceuticals, a company that specializes in radiopharmaceuticals. He has over 20 years of experience in the global pharmaceutical and biotech industries. Colin leads the medical, regulatory, clinical operations, and safety activities at Telix worldwide.He originally wanted to play football professionally for Brighton Hove Albion, but realized he wasn't good enough at age 12. Switched to field hockey, was academically gifted, loved science, and decided to pursue medicine to help people and dive deeper into science.About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

This podcast episode, Charles drops some real talk on communicating well when hiring people. He tells a story about how poor communication can really upset candidates and from this story, he gives three tips for hiring managers. This episode emphasizes that it's good to give rejected candidates helpful, positive feedback and to keep talking to them for possible jobs later on rather than ghosting them.He also shares three tips for hiring managers to protect their reputation and improve their interactions with candidates.Here's what you are in for:00:24 Why Protecting Your Reputation Matters00:44 How Feedback Can Strengthen Your Reputation02:23 Dealing with Rejection Positively07:22 Tips for Hiring Managers on Empowerment and Feedback07:56 Knowing How People Act at Work15:01 The Need for Empathy and Humility in Hiring17:40 Wrapping Up: Keeping Your Good Name at WorkAbout CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Ben Pais, Senior Vice President at Ariceum Therapeutics, discusses innovative cancer treatments. His company develops drugs that use radiation to combat cancer.He explains their strategies and adjustments in medical technology, focusing on radiotherapy. He talks about the challenges of producing and distributing these drugs and the importance of having capable leaders.Ben also explores future developments in this field and how large pharmaceutical companies acquiring smaller ones can impact the industry.Here's what you are in for:00:22 Moving from Clinical Medicine to Pharma02:00 Starting Out from Surgery to Pharma04:33 Discovering New Areas in Pharma08:50 Getting into Radiopharmaceuticals16:02 Growing in a Radiopharmaceutical Career19:25 Understanding Radiopharmaceuticals: Simple to Complex24:34 Finding Your Way in the Radiopharmaceutical Field33:57 What's Next for Radiopharmaceuticals and Career TipsAbout Ben PaisBen is a doctor with 25 years in the life science field. He knows about urology, cardiology, and radiation oncology. He has handled clinical trials (phase I-IV), medical affairs, drug safety, getting products to market, launching products, and early sales steps. Since 2019, he's been a certified Pharmaceutical Physician NVFG. In 2020, he started at Ipsen as the Global Development Lead for Radiopharmaceuticals. Later, he moved to Ariceum.About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles talks about how to craft authentic and genuine stories that can sell yourself and stand out from the rest. He points out that many resumes lack persuasive pitches and unique stories, so he offers 5 tips on creating these narratives. He stresses the need for authenticity and alignment with one's CV and interview responses.He also discusses typical mistakes, like not showing the hidden benefits or linking past experiences to what future employers are looking for.Here's what you are in for:01:03 A Sneak Peek at Making Your CV01:36 How to Make Sales Stories That Stick04:18 Knowing Your Audience is Your First Step to Win05:14 Being Specific on How to Make Stories Catchy10:42 Using Lessons for Future Wins11:26 The Secret to Job Applications12:45 Building a Strong Professional Image13:09 More Than Crafting a CV But Growing Your Career ChancesAbout CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles talks with Riccardo Canevari, the managing director and CEO of Radiopharm Theranostics, a company that is innovating the way we see cancer. They talked about his leadership journey in transitioning from leading 110k employees to a 3-man startup team. He also discusses launching innovative cancer treatments such as Luziterra and BluVicto and the challenges of selling them. He also highlights the importance of mission-driven work in biotech and the promise of radiopharmaceuticals in cancer treatment.Here's what you are in for:00:00 Ricardo's Journey From Milan to Pharma Leader00:19 Family's Influence in Early Life03:25 Ricardo's Career Path from Chemistry to Pharma05:38 Highs and Lows in Pharma Industry05:51 Leadership Lessons10:27 Taking the new role as the head of Radio Pharm17:59 Building a 3-man start up team30:24 Reflecting on Leadership and Advancement35:41 The Future of RadiotherapyAbout Riccardo CanevariRiccardo is an experienced leader in specialty pharma, cancer care, and radiopharmaceuticals. He served as the Chief Commercial Officer at Advanced Accelerator Applications, a leading company owned by Novartis. There, he led commercial strategies in around 20 countries. His main focus was on expanding the market for Lutathera and preparing for the launch of Lu-PSMA 617 to treat advanced prostate cancer. Before this, Riccardo held top positions at Novartis Oncology. He oversaw the successful introduction of breast cancer drugs like KISQALI and PIQRAY. He also gained extensive experience from different roles at Novartis Pharma and Ethicon/Johnson & Johnson.Connect with Riccardo:LinkedIn: https://www.linkedin.com/in/riccardo-canevari-7239931/Website: https://www.radiopharmtheranostics.com/About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, we're exploring the latest in radiotherapy, especially radioligand therapy for cancer treatment. Charles spotlights some promising trials coming up in 2024 that involve companies like Ymabs, Marianao Oncology, and many more fighting hard-to-treat cancers with new techniques and talks about big deals in the industry, like when Point Pharma and Ray's bio were bought. These deals show how important radiotherapy is in business and strategy. Looking ahead, Charles sees a bright future for radiotherapy, with better supply chains possibly making treatments cheaper and more accessible. Here's what you are in for:00:00 Introduction to New Radiotherapy Methods00:28 Understanding Radiotherapy Today02:14 Early Trials in Radiotherapy07:54 Key Trials and Their Effects on the Industry12:17 The Future of Radiotherapy13:21 Final Thoughts and What's NextAbout CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/ Website: https://www.discera-search.com/

In this episode, we talk about ADCs or antibody-drug conjugates with Ilaria Contis, a VP at ADC Therapeutics. This Swiss company is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs). It is known for being a one-stop-shop for ADC development, handling everything from research to selling their products.Ilaria shares about how ADCs (antibody-drug conjugates) are transforming cancer treatment, opportunities and challenges in ADC tech, and why global experience matters in pharma careers. Here's what you are in for:01:14 – Getting Into Medicine09:56 – Interest in ADCs11:25 – ADC’s History and Recent Developments21:13 – Business Development Perspective on ADCs25:38 – Expanding Beyond Hematology31:02 – US vs. Europe in Pharma and Biotech Careers40:28 – Inspiring the Next Generation About IlariaIlaria Contis is a pharmaceutical developer from Tuscany, Italy, where she spent her childhood. With a background in medicine and a strong drive for research, Ilaria was inspired by the groundbreaking work of Nobel Prize laureate Rita Levi-Montalcini to pursue a career in the medical field. Her journey led her to the United States, where she immersed herself in clinical research and eventually found her niche in the pharmaceutical industry, particularly focusing on the development of Antibody-Drug Conjugates (ADCs).Connect with Ilaria:LinkedIn: https://www.linkedin.com/in/ilaria-conti-581bb06/Website: https://www.adctherapeutics.com/About CharlesCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea) and also spent years doing research in diabetes. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/Website: https://www.discera-search.com/

In this episode, Charles covers the steps before applying, the application process, and how to negotiate your salary. He also explores the reasons behind the discomforts that may arise during these conversations and provides practical tips and strategies to help you navigate salary negotiations confidently.Here's what you are in for: 00:00 - Introduction01:49 - Salary Negotiation Topic Introduction03:14 - Pre-Application Advice08:11 - Research and Self-Value Assessment10:45 - Application Form and Recruiter Interaction13:05 - Interview Phase Strategy15:15 - Salary Negotiation ABOUT CHARLESCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea) and also spent years doing research in diabetes. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH. Connect with Charles on:Linkedin: linkedin.com/in/charles-spence-clinical Website: https://www.discera-search.com/

In this episode, we explore radiotherapy biotech with Mats Hansen. He is the CEO of Spago Nanomedical AB, a biotech firm advancing cancer treatment with new radiopharmaceuticals. Mats discusses the challenges and opportunities in the radiopharmaceutical space and provides insights into nanomedical radiopharmaceuticals for cancer treatment using lutetium-177. He also shares his experiences and insights on leadership and communication skills, emphasizing the importance of effective communication in leadership roles, and discusses how his approach to leadership has evolved over the years.Here's what you are in for: 00:00 Introduction05:08 - Experience in Drug Development 13:19 - The Role of AI on Pharma and BioTech15:19 - Spargo Nanomedical and Recent Developments23:15- Challenges and Opportunities in Radiopharmaceutical Space25:48 - Considerations for Investors 31:19 - Challenges and Growth as a CEOABOUT MATSMats Hansen, a scientist from southern Sweden, loves nature deeply and is curious and passionate about science. These driving forces propelled him to pursue a career in science and pharmaceutical development. Mats has come a long way, from his start in plant breeding and working with molecular markers to now being the CEO of Spago Nanomedical AB. By applying scientific knowledge in an industrial setting, he has adeptly navigated the challenges of drug development, continuously refining his skills in communication and leadership along the way. Connect with Mats on:LinkedIn: inkedin.com/in/matshansen1 Website: spagonanomedical.se   ABOUT CHARLESCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry. He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea) and also spent years doing research in diabetes. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/ Website: https://www.discera-search.com/

Welcome to “A Dose of Reality”, the podcast where we infuse insight, laughter, and practical wisdom into the world of clinical leadership and career development. Hosted by Charles Spence, each episode offers a deep dive into the challenges and triumphs of clinical leadership, providing listeners with meaningful conversations, career insights, and a dose of inspiration to navigate their professional journeys.Whether you're a director, a C-level executive, or a clinical researcher in oncology bio-techs, this podcast is designed to empower you with the knowledge and tools needed to excel in your field.So, visit our website at www.discera-search.com, and tune in to A Dose of Reality for your prescription of career wisdom, leadership insights, and a healthy dose of laughter. Subscribe now and join us on the journey to becoming global clinical leaders!